Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H OERTEL

Showing results (651-660 of 678) with videos related to

Pageof 68
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging IndicesPing Wu, Yu Zhao, Jianjun Wu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 19, 2012
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter studyFelix Rosenow, Carmen Schade-Brittinger, Nicole Burchardi, et al.
Annals of Neurology|January 4, 2022
Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior DisorderHui Zhang, Alex Iranzo, Birgit Högl, et al.
NPJ Parkinson'S Disease|July 1, 2026
Multimodal neuroimaging elucidates the posterior-to-anterior gradient of nigrostriatal degeneration in Parkinson's diseaseHuamei Lin, Ying Zhang, Yixin Zhao, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 27, 2016
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approachJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
The Lancet. Neurology|July 7, 2019
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2007
Clinical trials in restless legs syndrome--recommendations of the European RLS Study Group (EURLSSG)Claudia Trenkwalder, Ralf Kohnen, Richard P Allen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study groupT S Benamer, J Patterson, D G Grosset, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2009
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)Richard Dodel, Annika Spottke, Alexander Gerhard, et al.
Pageof 68

Showing results (651-660 of 678) with videos related to

Sort By:
Pageof 68
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging IndicesPing Wu, Yu Zhao, Jianjun Wu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 19, 2012
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter studyFelix Rosenow, Carmen Schade-Brittinger, Nicole Burchardi, et al.
Annals of Neurology|January 4, 2022
Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior DisorderHui Zhang, Alex Iranzo, Birgit Högl, et al.
NPJ Parkinson'S Disease|July 1, 2026
Multimodal neuroimaging elucidates the posterior-to-anterior gradient of nigrostriatal degeneration in Parkinson's diseaseHuamei Lin, Ying Zhang, Yixin Zhao, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 27, 2016
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approachJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
The Lancet. Neurology|July 7, 2019
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2007
Clinical trials in restless legs syndrome--recommendations of the European RLS Study Group (EURLSSG)Claudia Trenkwalder, Ralf Kohnen, Richard P Allen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study groupT S Benamer, J Patterson, D G Grosset, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2009
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)Richard Dodel, Annika Spottke, Alexander Gerhard, et al.
Pageof 68